Slovakia has been added to the group of European countries whose pharma manufacturing inspections systems are on par with those in the US, enabling the Food and Drug Administration to automatically recognise products produced in the country’s factories.
As a result, all 28 EU member states can now participate in a Mutual Recognition Agreement on good manufacturing practice (GMP) that was initiated in 1998, and slowly brought into force over the past 20 years. The European Commission announced the coming into effect of the full agreement on 11 July.